145 related articles for article (PubMed ID: 36800240)
1. Solitary Malignant Peripheral Nerve Sheath Tumor of Lumbar Vertebra Mimicking Metastatic Malignancy.
Guo Z; Liu W; Dong Z; Yang L; Xie P
Clin Nucl Med; 2023 May; 48(5):435-436. PubMed ID: 36800240
[TBL] [Abstract][Full Text] [Related]
2. Solitary Lymph Node Metastasis From a Malignant Peripheral Nerve Sheath Tumor of the Thoracic Vertebra Revealed on FDG PET/CT.
Xiao L; Li Y; Li L
Clin Nucl Med; 2022 May; 47(5):e419-e420. PubMed ID: 35234201
[TBL] [Abstract][Full Text] [Related]
3. Malignant Peripheral Nerve Sheath Tumor With Bilateral Adrenal Metastases: Role of 18F-FDG PET/CT in Response Assessment to Tyrosine Kinase Inhibitor and Liposomal Doxorubicin.
Tripathy S; Passah A; Singhal A; Prashanth A; Kumar R
Clin Nucl Med; 2019 Jun; 44(6):494-495. PubMed ID: 30889004
[TBL] [Abstract][Full Text] [Related]
4. Malignant Peripheral Nerve Sheath Tumor Arising From Transplanted Kidney Assessed by 18F-FDG PET/CT.
Feng H; Tu N; Bu L
Clin Nucl Med; 2020 Nov; 45(11):905-907. PubMed ID: 32969901
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT of an Advanced Case of Malignant Nerve Sheath Tumor of Pleura.
Saidi B; Fallahi B; Abdi A; Rakhshani N; Eftekhari M
Clin Nucl Med; 2021 Mar; 46(3):246-247. PubMed ID: 33492853
[TBL] [Abstract][Full Text] [Related]
6. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
8. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of
Cook GJR; Lovat E; Siddique M; Goh V; Ferner R; Warbey VS
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1845-1852. PubMed ID: 28589254
[TBL] [Abstract][Full Text] [Related]
11. Giant Melanotic Malignant Peripheral Nerve Sheath Tumor in the Pelvis: Contrast-Enhanced CT and 18F-FDG PET/CT Finding.
Liu E; Sun T; Liu C; Wang S; Wang S
Clin Nucl Med; 2019 Nov; 44(11):895-897. PubMed ID: 31274561
[TBL] [Abstract][Full Text] [Related]
12. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT Helps Differentiate Peripheral Nerve Myeloid Sarcoma From a Presumed Benign Nerve Sheath Tumor.
Das JP; Riedl CC; Ulaner GA
Clin Nucl Med; 2020 Dec; 45(12):989-991. PubMed ID: 32956122
[TBL] [Abstract][Full Text] [Related]
14. Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review.
Luna R; Fayad LM; Rodriguez FJ; Ahlawat S
Skeletal Radiol; 2021 Jan; 50(1):201-215. PubMed ID: 32699955
[TBL] [Abstract][Full Text] [Related]
15. Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Bertagna F; Bosio G; Biasiotto G; Savelli G; Rodella C; Giubbini R; Rosenbaum J; Alavi A
Jpn J Radiol; 2009 Oct; 27(8):320-3. PubMed ID: 19856228
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal Chronic Expanding Hematoma Mimicking Malignancy on FDG PET/CT.
Narita H; Takenaka J; Watanabe S; Abe T; Kudo K
Clin Nucl Med; 2022 Sep; 47(9):e591-e593. PubMed ID: 35485848
[TBL] [Abstract][Full Text] [Related]
17. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1.
Warbey VS; Ferner RE; Dunn JT; Calonje E; O'Doherty MJ
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):751-7. PubMed ID: 19142634
[TBL] [Abstract][Full Text] [Related]
18. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
Meany H; Dombi E; Reynolds J; Whatley M; Kurwa A; Tsokos M; Salzer W; Gillespie A; Baldwin A; Derdak J; Widemann B
Pediatr Blood Cancer; 2013 Jan; 60(1):59-64. PubMed ID: 22645095
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
Chander S; Westphal SM; Zak IT; Bloom DA; Zingas AP; Joyrich RN; Littrup PJ; Taub JW; Getzen TM
Clin Nucl Med; 2004 Jul; 29(7):415-8. PubMed ID: 15192465
[TBL] [Abstract][Full Text] [Related]
20. A case of von Recklinghausen's disease with coincident malignant peripheral nerve sheath tumor and gastrointestinal stromal tumor.
Otomi Y; Otsuka H; Morita N; Terazawa K; Harada M; Nishitani H
J Med Invest; 2009 Feb; 56(1-2):76-9. PubMed ID: 19262018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
